<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11770">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02132806</url>
  </required_header>
  <id_info>
    <org_study_id>UNITS01-2014</org_study_id>
    <nct_id>NCT02132806</nct_id>
  </id_info>
  <brief_title>Piezosurgery in the Treatment of Class II Furcation Involvement</brief_title>
  <official_title>Piezosurgery in the Treatment of Class II Furcation Involvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Matteo Visintin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Trieste</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of piezosurgery in the treatment
      of class II furcation involvement using biomaterials and new surgical techniques
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Horizontal probing depth (PH)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>horizontal probing depth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque index (PI)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>plaque index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing (BoP)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>bleeding on probing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pocket probing depth (PPD)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>pocket probing depth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Furcation closure (FC)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>furcation closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level (CAL)</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>clinical attachment level</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Furcation Defects</condition>
  <arm_group>
    <arm_group_label>OFD with piezosurgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open flap debridement with Piezosurgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFD with piezosurgery+biomaterial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open flap debridement with Piezosurgery with biomaterial mp3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFD with piezosurgery+mp3+bracket</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open flap debridement with Piezosurgery with biomaterial mp3 + bracket</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Piezosurgery with biomaterial mp3 + bracket</intervention_name>
    <arm_group_label>OFD with piezosurgery+mp3+bracket</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Piezosurgery with biomaterial mp3</intervention_name>
    <arm_group_label>OFD with piezosurgery+biomaterial</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Piezosurgery</intervention_name>
    <arm_group_label>OFD with piezosurgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previous subgingival instrumentation with adequate plaque control (FMPS &lt; 20%) and
             bleeding on probing  (FMBS &lt; 20%).

          -  one or more mandibular molar with buccal class-II furcation involvement

        Exclusion Criteria:

          -  diabetes mellitus

          -  pregnancy and lactation period

          -  subjects smoking &gt; 10 cigarettes/day were excluded

          -  subjects in chronically treatment with calcium antagonist, immunosuppressive drugs
             and Antiepileptic Drugs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matteo Visintin</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCO Clinica Odontoiatrica e Stomatologica - Ospedale Maggiore Trieste</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matteo Visintin</last_name>
    <phone>00393338957896</phone>
    <email>matteo.visintin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Matteo Visintin</name>
      <address>
        <city>Trieste</city>
        <state>TS</state>
        <zip>34100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Visintin</last_name>
      <phone>00393338957896</phone>
      <email>matteo.visintin@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Matteo Visintin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>May 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Trieste</investigator_affiliation>
    <investigator_full_name>Matteo Visintin</investigator_full_name>
    <investigator_title>Student</investigator_title>
  </responsible_party>
  <keyword>class II furcation involvement</keyword>
  <keyword>piezoelectric surgery</keyword>
  <keyword>regeneration</keyword>
  <keyword>biomaterial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Furcation Defects</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
